CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Revenio Group Oyj Company Snapshot
Revenio Group Oyj operates in the Electromedical equipment sector. In addition to historical fundamental analyses, the complete report available to purchase compares Revenio Group Oyj with three other medical equipment manufacturers in Europe: Supersonic Imagine Sa of France (2017 sales of 24.70 million Euro [US$30.34 million] ), Omega Diagnostics Group Plc of the United Kingdom (£14.25 million [US$19.95 million] of which 56% was Food Intolerance), and Cellavision AB which is based in Sweden (309.31 million Swedish Kronor [US$36.62 million] of which 100% was Automatic Microscopy).

Sales Analysis. Revenio Group Oyj reported sales of 26.79 million Euro (US$32.91 million) for the year ending December of 2017. This represents an increase of 14.3% versus 2016, when the company's sales were 23.43 million Euro. This was the third consecutive year of growth at Revenio Group Oyj. The sales level in 2017 was fairly close to the level five years ago: in 2012, Revenio Group Oyj had sales of 25.38 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Revenio Group Oyj
  Stock Performance Chart for Revenio Group Oyj
 
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 14.18
(Figures in Euro)
1 Week 2.8%   13 Weeks 10.4%  
4 Weeks 16.9%   52 Weeks 14.4%  
 
Revenio Group Oyj Key Data:
  Ticker: REG1V Country: Finland
  Exchanges: HEL Major Industry: Health Care Equipment & Services
    Sub Industry: Electromedical Equipment
  2017 Sales 26,791,000
(Year Ending Jan 2018).
Employees: 41
  Currency: Euro Market Cap: 339,296,785
  Fiscal Yr Ends: December Shares Outstanding: 23,928,080
  Share Type: Osake Closely Held Shares: 5,294,571
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.